$OPRX
OptimizeRx Corp Stock $oprx

$oprx Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024069700 Filed on August 15, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$21.31M	$18.81M	$13.82M
YoY Change	30.48%	36.14%	-1.15%
Cost Of Revenue	$7.862M	$7.108M	$5.993M
YoY Change	20.38%	18.6%	20.13%
Gross Profit	$13.45M	$11.70M	$7.825M
YoY Change	37.21%	49.57%	-12.96%
Gross Profit Margin	63.1%	62.22%	56.63%
Selling, General & Admin	$13.43M	$14.38M	$12.24M
YoY Change	4.17%	17.46%	-0.63%
% of Gross Profit	99.84%	122.86%	156.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.095M	$1.073M	$464.8K
YoY Change	132.98%	130.87%	-19.61%
% of Gross Profit	8.14%	9.17%	5.94%
Operating Expenses	$22.01M	$15.45M	$12.71M
YoY Change	64.81%	21.61%	-1.49%
Operating Profit	-$8.562M	-$3.749M	-$4.882M
YoY Change	140.95%	-23.21%	24.9%
Interest Expense	-$1.417M	-$1.422M	$720.4K
YoY Change	-305.36%	-297.38%	2924.43%
% of Operating Profit
Other Income/Expense, Net	-$1.379M	-$1.347M	$720.4K
YoY Change	-300.38%	-286.97%	2924.94%
Pretax Income	-$9.941M	-$5.096M	-$4.161M
YoY Change	246.94%	22.46%	7.12%
Income Tax	-$817.0K	-$1.088M
% Of Pretax Income
Net Earnings	-$9.124M	-$4.008M	-$4.161M
YoY Change	218.43%	-3.69%	7.12%
Net Earnings / Revenue	-42.82%	-21.31%	-30.12%
Basic Earnings Per Share	-$0.50	-$0.22	-$0.24
Diluted Earnings Per Share	-$0.50	-$0.22	-$0.24
COMMON SHARES
Basic Shares Outstanding	18.32M shares	18.18M shares	17.13M shares
Diluted Shares Outstanding	18.32M shares	18.26M shares	16.99M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.13M	$14.96M	$62.74M
YoY Change	-74.6%	-76.16%	-28.21%
Cash & Equivalents	$16.13M	$14.96M	$9.808M
Short-Term Investments			$52.93M
Other Short-Term Assets	$4.389M	$4.647M	$4.053M
YoY Change	46.3%	14.66%	-5.33%
Inventory
Prepaid Expenses
Receivables	$26.33M	$24.52M	$18.28M
Other Receivables	$64.00K	$1.842M	$0.00
Total Short-Term Assets	$46.91M	$45.97M	$85.07M
YoY Change	-46.33%	-45.97%	-22.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$161.0K	$171.0K	$141.0K
YoY Change	7.83%	21.3%	-66.58%
Goodwill	$70.90M	$78.36M	$22.67M
YoY Change	212.7%	245.58%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$362.0K	$434.0K
YoY Change	-67.09%
Total Long-Term Assets	$118.3M	$126.9M	$36.25M
YoY Change	223.74%	250.08%	-2.13%
TOTAL ASSETS
Total Short-Term Assets	$46.91M	$45.97M	$85.07M
Total Long-Term Assets	$118.3M	$126.9M	$36.25M
Total Assets	$165.2M	$172.9M	$121.3M
YoY Change	33.3%	42.49%	-17.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.754M	$2.980M	$817.8K
YoY Change	293.43%	264.4%	-36.9%
Accrued Expenses	$5.557M	$5.310M	$1.503M
YoY Change	78.74%	253.18%	-12.92%
Deferred Revenue	$786.0K	$1.054M	$451.0K
YoY Change	318.09%	133.7%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.000M	$3.300M
YoY Change
Total Short-Term Liabilities	$14.50M	$14.96M	$5.510M
YoY Change	88.3%	171.45%	-14.46%
LONG-TERM LIABILITIES
Long-Term Debt	$33.28M	$32.30M	$0.00
YoY Change
Other Long-Term Liabilities	$242.0K	$271.0K	$0.00
YoY Change	142.0%		-100.0%
Total Long-Term Liabilities	$33.28M	$32.30M	$0.00
YoY Change	33178.0%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.50M	$14.96M	$5.510M
Total Long-Term Liabilities	$33.28M	$32.30M	$0.00
Total Liabilities	$50.73M	$51.86M	$5.510M
YoY Change	548.57%	841.25%	-16.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.29M	-$75.17M	-$57.25M
YoY Change	40.21%	31.29%
Common Stock	$20.00K	$20.00K	$18.38K
YoY Change	8.77%	8.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.000K	$2.000K	$1.741K
YoY Change	14.88%	14.88%
Treasury Stock Shares
Shareholders Equity	$114.5M	$121.0M	$115.8M
YoY Change
Total Liabilities & Shareholders Equity	$165.2M	$172.9M	$121.3M
YoY Change	33.3%	42.49%	-17.72%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$9.124M	-$4.008M	-$4.161M
YoY Change	218.43%	-3.69%	7.12%
Depreciation, Depletion And Amortization	$1.095M	$1.073M	$464.8K
YoY Change	132.98%	130.87%	-19.61%
Cash From Operating Activities	$1.791M	$782.0K	-$2.368M
YoY Change	21.84%	-133.02%	-868.56%
INVESTING ACTIVITIES
Capital Expenditures	$92.00K	$85.00K	$1.103M
YoY Change	-71.25%	-92.3%	-4207.56%
Acquisitions
YoY Change
Other Investing Activities			$4.326M
YoY Change			-306.61%
Cash From Investing Activities	-$92.00K	-$85.00K	$3.223M
YoY Change	-90.89%	-102.64%	-251.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-532.0K	-915.0K	-7.490M
YoY Change	52.0%	-87.78%	-3080.74%
NET CHANGE
Cash From Operating Activities	1.791M	782.0K	-2.368M
Cash From Investing Activities	-92.00K	-85.00K	3.223M
Cash From Financing Activities	-532.0K	-915.0K	-7.490M
Net Change In Cash	1.167M	-218.0K	-6.635M
YoY Change	960.91%	-96.71%	324.96%
FREE CASH FLOW
Cash From Operating Activities	$1.791M	$782.0K	-$2.368M
Capital Expenditures	$92.00K	$85.00K	$1.103M
Free Cash Flow	$1.699M	$697.0K	-$3.471M
YoY Change	47.74%	-120.08%	-1136.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Trading Symbol TradingSymbol	OPRX
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38543
	dei	Entity Registrant Name EntityRegistrantName	OptimizeRx Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1265381
	dei	Entity Address Address Line1 EntityAddressAddressLine1	260 Charles Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 302
	dei	Entity Address City Or Town EntityAddressCityOrTown	Waltham
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02453
	dei	City Area Code CityAreaCode	248
	dei	Local Phone Number LocalPhoneNumber	651-6568
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18321886	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14959000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13852000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	371000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	480000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24521000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36253000	usd
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1842000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1036000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4647000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3190000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	45969000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	54331000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	78357000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	78357000	usd
CY2024Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	14470000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	15198000	usd
CY2024Q2	oprx	Tradename And Customer Relationships Net Current TradenameAndCustomerRelationshipsNetCurrent	33003000	usd
CY2023Q4	oprx	Tradename And Customer Relationships Net Current TradenameAndCustomerRelationshipsNetCurrent	34198000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	472000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	573000	usd
CY2024Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	434000	usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	568000	usd
CY2024Q2	oprx	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	126736000	usd
CY2023Q4	oprx	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	128894000	usd
CY2024Q2	us-gaap	Assets Assets	172876000	usd
CY2023Q4	us-gaap	Assets Assets	183374000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3300000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2024Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2980000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2227000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5310000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7706000	usd
CY2024Q2	oprx	Revenue Share Payable Current RevenueSharePayableCurrent	2094000	usd
CY2023Q4	oprx	Revenue Share Payable Current RevenueSharePayableCurrent	5506000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	49000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	219000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	222000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1053000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	172000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14956000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17882000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32296000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34231000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	271000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	371000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4337000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4337000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	51860000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	56821000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	166666667	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	166666667	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20061907	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19899679	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2024Q2	oprx	Treasury Stock Par Value TreasuryStockParValue	0.001
CY2023Q4	oprx	Treasury Stock Par Value TreasuryStockParValue	0.001
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	196164000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	190793000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-75166000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64258000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	121016000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	126553000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172876000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183374000	usd
CY2024Q2	us-gaap	Revenues Revenues	18812000	usd
CY2023Q2	us-gaap	Revenues Revenues	13818000	usd
	us-gaap	Revenues Revenues	38502000	usd
	us-gaap	Revenues Revenues	26821000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	7108000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	5993000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14595000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	11563000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	11704000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	7825000	usd
	us-gaap	Gross Profit GrossProfit	23907000	usd
	us-gaap	Gross Profit GrossProfit	15258000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14380000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12209000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30545000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26208000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1073000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	465000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2140000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	929000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	15453000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	12674000	usd
	us-gaap	Operating Expenses OperatingExpenses	32685000	usd
	us-gaap	Operating Expenses OperatingExpenses	27137000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3749000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4849000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8778000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11879000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1528000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3074000	usd
CY2024Q2	us-gaap	Other Income OtherIncome	75000	usd
	us-gaap	Other Income OtherIncome	75000	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	106000	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	721000	usd
	us-gaap	Interest Income Other InterestIncomeOther	125000	usd
	us-gaap	Interest Income Other InterestIncomeOther	1386000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1347000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	721000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2874000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1386000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5096000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4128000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11652000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10493000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1088000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-744000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	66000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4008000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4161000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10908000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10559000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18257879	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16992100	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18213992	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17043493	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18257879	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16992100	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18213992	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17043493	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	126553000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1353000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1671000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-140000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6900000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	122537000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1149000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1753000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-415000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4008000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	121016000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	126111000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1467000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2914000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-171000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6398000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	123963000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1655000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1848000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	105000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-73000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7522000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4161000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	115815000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10908000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10559000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2140000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	929000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5926000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7884000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	132000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	239000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	365000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11600000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3635000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1457000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1772000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	752000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-732000	usd
	oprx	Increase Decrease In Revenue Share Payable IncreaseDecreaseInRevenueSharePayable	-3412000	usd
	oprx	Increase Decrease In Revenue Share Payable IncreaseDecreaseInRevenueSharePayable	-1269000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2264000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1097000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-855000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	881000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	287000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2455000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	77000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	49000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	109501000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	112501000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000	usd
	oprx	Capitalized Software Development Costs CapitalizedSoftwareDevelopmentCosts	161000	usd
	oprx	Capitalized Software Development Costs CapitalizedSoftwareDevelopmentCosts	1274000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-238000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1674000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	555000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	244000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	145000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7522000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1555000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7621000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1107000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8402000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13852000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18210000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14959000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9808000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2710000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	110000	usd
	oprx	Number Of Us Providers NumberOfUSProviders	2000000	pure
CY2023Q4	oprx	Issued And Outstanding Share Percentage IssuedAndOutstandingSharePercentage	1	pure
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	22408000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	43439000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-6076000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-14708000	usd
CY2024Q2	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	1213000	usd
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	3080000	usd
CY2024Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	8100000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	71000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	141000	usd
CY2023Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	48000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	95000	usd
CY2024Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	393000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	696000	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	4134000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3288000	usd
	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	26766000	usd
CY2023	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	2021000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1053000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	172000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	172000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3228000	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2444000	usd
CY2024Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	3.961	usd
CY2023Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	3015000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	905000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	735000	usd
CY2024Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1853000	usd
CY2023Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3171000	usd
CY2024Q2	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	2002000	usd
CY2023Q2	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	2887000	usd
CY2024Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1054000	usd
CY2023Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	451000	usd
CY2024Q2	us-gaap	Revenues Revenues	18812000	usd
CY2023Q2	us-gaap	Revenues Revenues	13818000	usd
	us-gaap	Revenues Revenues	38502000	usd
	us-gaap	Revenues Revenues	26821000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	239000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	352000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	132000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	128000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	371000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	480000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	371000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	591000	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	37290000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	38290000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3300000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2024Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	1694000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2059000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32296000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34231000	usd
CY2024Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.141	pure
	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.162	pure
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	182000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	365000	usd
CY2023Q4	oprx	Percentage Of Repayable Term Loan PercentageOfRepayableTermLoan	0.0125	pure
CY2023Q4	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	500000000	usd
	oprx	Leverage Ratio Describtion LeverageRatioDescribtion	In addition, the Company is required to make a mandatory prepayment on March 31, of each year, commencing with 2025, equivalent to Excess Cash Flow multiplied by a percentage factor of 25%, if the leverage ratio is 3.60 to 1.00 or less, 50% if the leverage ratio is greater than 3.60 to 1 or less than or equal; to 4.10 to 1.00 and 75%, if the leverage ratio is greater than 4.10 to 1.00.
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3300000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	30990000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	37290000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	62000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	25000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	124000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	49000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	62000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	25000	usd
	us-gaap	Lease Cost LeaseCost	125000	usd
	us-gaap	Lease Cost LeaseCost	57000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	132000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	186000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	113000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	65000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	45000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	541000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	52000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	489000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0685	pure
CY2024Q2	us-gaap	Lease Deposit Liability LeaseDepositLiability	109000	usd
CY2023Q2	us-gaap	Lease Deposit Liability LeaseDepositLiability	45000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	127000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	49000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	113000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	49000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18158282	shares
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	140028	shares
	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	48281	shares
	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	555007000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	33272	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	35260	shares
CY2023Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	23217	shares
	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	244000	usd
CY2023Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	usd
CY2023Q2	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	526999	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7522000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4450000	shares
	oprx	Remaining Expenses RemainingExpenses	5031000	usd
	oprx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P1Y6M25D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	214000	usd
	oprx	Restricted Stock Granted Remains Value RestrictedStockGrantedRemainsValue	8337000	usd
	oprx	Remains To Be Recognized Weighted Average Period RemainsToBeRecognizedWeightedAveragePeriod	P1Y6M7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	402000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	352000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4008000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4161000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10908000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10559000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18257879	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16992100	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18213992	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17043493	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18257879	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16992100	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18213992	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17043493	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	88132	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	49845	shares
CY2024Q2	us-gaap	Other Commitment OtherCommitment	18500000	usd
CY2024Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	3900000	usd
CY2024Q2	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	8500000	usd
CY2024Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	3600000	usd
CY2024Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	2400000	usd
CY2024Q2	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	100000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1088000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-744000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.064	pure
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	16700000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating		usd
CY2023Q2	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit		usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001448431

Files In Submission

Name	View Source	Status
0001213900-24-069700-index-headers.html	Edgar Link	pending
0001213900-24-069700-index.html	Edgar Link	pending
0001213900-24-069700.txt	Edgar Link	pending
0001213900-24-069700-xbrl.zip	Edgar Link	pending
ea0211425-10q_optimizerx.htm	Edgar Link	pending
ea0211425-10q_optimizerx_htm.xml	Edgar Link	completed
ea021142501ex31-1_optimizerx.htm	Edgar Link	pending
ea021142501ex31-2_optimizerx.htm	Edgar Link	pending
ea021142501ex32-1_optimizerx.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oprx-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
oprx-20240630_def.xml	Edgar Link	unprocessable
oprx-20240630_lab.xml	Edgar Link	unprocessable
oprx-20240630_pre.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
oprx-20240630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPRX
OptimizeRx Corp Stock $oprx

2024 Q3 Form 10-Q Financial Statement

#000121390024069700 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPRX OptimizeRx Corp Stock $oprx

2024 Q3 Form 10-Q Financial Statement

#000121390024069700 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPRX
OptimizeRx Corp Stock $oprx